#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14470	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2584	672.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1699	1699	C	864	C,T	861,3	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14470	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2584	672.8	0	HET	.	.	.	C831T,G	.	831	831	C	1346	1346	C	939	C,T,G	694,244,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14470	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2584	672.8	0	HET	.	.	.	C1450T,G	.	1450	1450	C	1965	1965	C	915	C,T,G	683,231,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14470	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2584	672.8	0	HET	.	.	.	C611T,G	.	611	611	C	1126	1126	C	839	C,T,G	633,204,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23942	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3994	745.1	0	.	n	.	0	T695C	SNP	695	695	T	1217	1217	C	923	C,T	921,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23942	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3994	745.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1859	1859	A	984	A,C,T,G	978,3,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23942	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3994	745.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2493	2493	C	839	C	839	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23942	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3994	745.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2567	2567	A	786	A,G,T,C	781,3,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23942	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3994	745.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3119	3119	C	840	C,G,T	837,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23942	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3994	745.1	0	HET	.	.	.	C2632T	.	2632	2632	C	3154	3154	C	829	C,T	398,431	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	31200	blaTEM	861	861	100.0	blaTEM.l15.c4.ctg.1	2158	1798.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	539	2134	folP	852	852	99.88	folP.l15.c4.ctg.1	2139	124.1	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1115	1117	AAA	201;203;206	A;A;A,C	201;203;205,1	.	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	539	2134	folP	852	852	99.88	folP.l15.c4.ctg.1	2139	124.1	1	SNP	p	R228S	1	.	.	682	684	AGC	1346	1348	AGC	202;204;206	A;G;C	202;204;206	folP.WHO_U_01433c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4804	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4055	147.7	1	SNP	p	S91F	0	.	.	271	273	TCC	935	937	TCC	179;179;182	T;C;C	178;178;181	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4804	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4055	147.7	1	SNP	p	D95G	0	.	.	283	285	GAC	947	949	GAC	185;186;189	G;A;C	184;185;188	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4804	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4055	147.7	1	SNP	p	D95N	0	.	.	283	285	GAC	947	949	GAC	185;186;189	G;A;C	184;185;188	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	539	1726	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	2070	104.0	0	.	p	.	0	A39T	NONSYN	115	117	GCC	854	856	ACC	156;158;158	A;C;C	156;158;158	.	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	539	1726	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	2070	104.0	0	.	p	.	0	I196fs	FSHIFT	586	586	A	1325	1325	A	194	A	194	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1094	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	1697	80.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4870	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3819	159.0	1	SNP	p	D86N	0	.	.	256	258	GAC	975	977	GAC	207;208;211	G;A,C;C	207;207,1;211	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4870	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3819	159.0	1	SNP	p	S87W	0	.	.	259	261	AGT	978	980	AGT	210;209;209	A,G;G,C;T,C	209,1;208,1;208,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4870	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3819	159.0	1	SNP	p	S87R	0	.	.	259	261	AGT	978	980	AGT	210;209;209	A,G;G,C;T,C	209,1;208,1;208,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4870	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3819	159.0	1	SNP	p	S87I	0	.	.	259	261	AGT	978	980	AGT	210;209;209	A,G;G,C;T,C	209,1;208,1;208,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4870	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3819	159.0	1	SNP	p	S88P	0	.	.	262	264	TCC	981	983	TCC	209;210;209	T;C;C,G	209;210;208,1	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3964	parE	1986	1986	100.0	parE.l6.c30.ctg.1	3430	144.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1979	1981	GGC	216;214;213	G;G;C	216;214;213	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.4.001	penA.4.001	1	1	27	3748	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2988	156.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1532	1534	GCA	214;215;216	G,T;C,G,A;A	213,1;213,1,1;216	penA.4.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3748	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2988	156.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1535	1537	ATC	217;216;215	A,C;T,C,A;C	214,3;214,1,1;215	penA.4.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3748	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2988	156.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1547	1549	GTG	216;215;213	G,C;T,G;G	215,1;213,2;213	penA.4.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3748	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2988	156.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1547	1549	GTG	216;215;213	G,C;T,G;G	215,1;213,2;213	penA.4.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3748	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2988	156.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2051	2053	ACC	190;188;188	A,G;C;C,T,G	189,1;188;186,1,1	penA.4.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3748	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2988	156.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2105	2107	GCG	197;197;196	G;C;G	197;197;196	penA.4.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3748	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2988	156.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2105	2107	GCG	197;197;196	G;C;G	197;197;196	penA.4.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3748	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2988	156.1	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2228	2230	AGC	216;214;216	A,G;G;C,G	215,1;214;215,1	penA.4.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3748	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2988	156.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2237	2239	GGC	222;223;223	G;G;C,G	222;223;222,1	penA.4.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3748	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2988	156.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2255	2257	CCG	219;218;226	C,T,G;C,T;G,A	217,1,1;217,1;225,1	penA.4.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5114	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3770	168.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2320	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2573	112.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	957	957	C	164	C	164	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	292	90.2	porB1a.l15.c17.ctg.1	1043	28.2	0	.	p	.	0	H217N	NONSYN	649	651	CAT	776	778	AAT	26;26;26	A;A;T	26;26;26	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	292	90.2	porB1a.l15.c17.ctg.1	1043	28.2	0	.	p	.	0	D218N	NONSYN	652	654	GAT	779	781	AAT	26;26;26	A;A;T	26;26;26	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	292	90.2	porB1a.l15.c17.ctg.1	1043	28.2	0	.	p	.	0	V226A	NONSYN	676	678	GTA	803	805	GCA	22;22;22	G;C;A	22;22;22	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	292	90.2	porB1a.l15.c17.ctg.1	1043	28.2	0	.	p	.	0	.	MULTIPLE	700	702	ACT	826	828	GTA	21;21;21	G;T;A	21;21;21	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	292	90.2	porB1a.l15.c17.ctg.1	1043	28.2	0	.	p	.	0	S236N	NONSYN	706	708	AGC	832	834	AAC	21;21;21	A;A;C	21;21;21	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	292	90.2	porB1a.l15.c17.ctg.1	1043	28.2	0	.	p	.	0	.	MULTIPLE	709	711	AAC	836	840	TGGCG	21;21;21;21;21	T;G;G;C;G	21;21;21;21;21	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	292	90.2	porB1a.l15.c17.ctg.1	1043	28.2	0	.	p	.	0	D238A	NONSYN	712	714	GAT	842	844	GCT	21;21;21	G;C;T	21;21;21	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	292	90.2	porB1a.l15.c17.ctg.1	1043	28.2	0	.	p	.	0	A251V	NONSYN	751	753	GCG	881	883	GTA	23;23;22	G;T;A	23;23;22	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	292	90.2	porB1a.l15.c17.ctg.1	1043	28.2	0	.	p	.	0	S271T	NONSYN	811	813	TCG	941	943	ACT	74;74;74	A;C;T	74;74;74	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	292	90.2	porB1a.l15.c17.ctg.1	1043	28.2	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	947	949	GAT	74;74;74	G;A;T	74;74;74	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	292	90.2	porB1a.l15.c17.ctg.1	1043	28.2	0	.	p	.	0	D276N	NONSYN	826	828	GAT	956	958	AAC	74;74;73	A;ACC,AC;C	73;72,1;73	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	292	90.2	porB1a.l15.c17.ctg.1	1043	28.2	0	.	p	.	0	N277H	NONSYN	829	831	AAC	959	961	CAC	74;74;74	C;A;C	73;74;74	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2972	porB1b	1041	1041	99.42	porB1b.l15.c17.ctg.1	2173	169.7	0	.	p	.	0	T26A	NONSYN	76	78	ACC	729	731	GCC	232;233;233	G,T;C;C,G	231,1;233;232,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2972	porB1b	1041	1041	99.42	porB1b.l15.c17.ctg.1	2173	169.7	0	.	p	.	0	K41D	NONSYN	121	123	AAA	774	776	GAC	222;223;225	G,A;A,G;C	221,1;222,1;225	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2972	porB1b	1041	1041	99.42	porB1b.l15.c17.ctg.1	2173	169.7	0	.	p	.	0	G140R	NONSYN	418	420	GGA	1071	1073	AGA	246;247;247	A;G,C;A,G	246;246,1;246,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2972	porB1b	1041	1041	99.42	porB1b.l15.c17.ctg.1	2173	169.7	1	SNP	p	G120K	1	.	.	358	360	AAG	1011	1013	AAG	242;241;243	A;A;G	242;241;243	porB1b.WHO_O_01976:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2972	porB1b	1041	1041	99.42	porB1b.l15.c17.ctg.1	2173	169.7	1	SNP	p	A121D	1	.	.	361	363	GAC	1014	1016	GAC	244;244;244	G;A,T;C	244;243,1;244	porB1b.WHO_O_01976:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2972	porB1b	1041	1041	99.42	porB1b.l15.c17.ctg.1	2173	169.7	1	SNP	p	D121N	0	.	.	361	363	GAC	1014	1016	GAC	244;244;244	G;A,T;C	244;243,1;244	porB1b.WHO_O_01976:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	9646	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5723	210.2	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2464	2466	AAT	250;251;249	A,C,G,T;A,C;T,C	244,4,1,1;250,1;248,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1360	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1745	97.2	1	SNP	p	V57M	1	.	.	169	171	ATG	878	880	ATG	236;235;236	A;T;G	236;235;236	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
